Literature DB >> 34249411

The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.

Junmin Wang1,2, Hongjiao Xiang1,2, Yifei Lu1,2, Tao Wu1,2, Guang Ji2.   

Abstract

Cancer cells must maintain metabolic homeostasis under a wide range of conditions and meet their own energy needs in order to survive and reproduce. In addition to glycolysis, cancer cells can also perform various metabolic strategies, such as fatty acid oxidation (FAO). It has been found that the proliferation, survival, drug resistance and metastasis of cancer cells depend on FAO. The carnitine palmitoyltransferase (CPT), including CPT1 and CPT2, located on the mitochondrial membrane, are important mediators of FAO. In recent years, many researchers have found that CPT has a close relationship with the metabolic development of tumor cells, not only provides energy for cancer cells development and metastasis by promoting FAO but also affects the occurrence and invasion through other signal pathways or cytokines or microRNA. This review summarized the role of CPTs in several kinds of tumors and the developed targeted inhibitors of CPTs, as well as the potential gene therapy and immunotherapy of CPTs, hoping to better explore the mechanism and role of CPTs in the future and providing useful ideas for clinical treatment. AJCR
Copyright © 2021.

Entities:  

Keywords:  CPT1; CPT2; FAO; cancers; inhibitors

Year:  2021        PMID: 34249411      PMCID: PMC8263643     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  151 in total

Review 1.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.

Authors:  J D McGarry; N F Brown
Journal:  Eur J Biochem       Date:  1997-02-15

2.  Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD.

Authors:  Minéia Weber; Paula Mera; Josefina Casas; Javier Salvador; Amaia Rodríguez; Sergio Alonso; David Sebastián; M Carmen Soler-Vázquez; Carla Montironi; Sandra Recalde; Raquel Fucho; María Calderón-Domínguez; Joan Francesc Mir; Ramon Bartrons; Joan Carles Escola-Gil; David Sánchez-Infantes; Antonio Zorzano; Vicenta Llorente-Cortes; Núria Casals; Víctor Valentí; Gema Frühbeck; Laura Herrero; Dolors Serra
Journal:  FASEB J       Date:  2020-07-15       Impact factor: 5.191

3.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.

Authors:  Kathrin Zaugg; Yi Yao; Patrick T Reilly; Karuppiah Kannan; Reza Kiarash; Jacqueline Mason; Ping Huang; Suzanne K Sawyer; Benjamin Fuerth; Brandon Faubert; Tuula Kalliomäki; Andrew Elia; Xunyi Luo; Vincent Nadeem; David Bungard; Sireesha Yalavarthi; Joseph D Growney; Andrew Wakeham; Yasmin Moolani; Jennifer Silvester; Annick You Ten; Walbert Bakker; Katsuya Tsuchihara; Shelley L Berger; Richard P Hill; Russell G Jones; Ming Tsao; Murray O Robinson; Craig B Thompson; Guohua Pan; Tak W Mak
Journal:  Genes Dev       Date:  2011-05-15       Impact factor: 11.361

4.  Inter-related in vitro effects of androgens, fatty acids and oxidative stress in prostate cancer: a mechanistic model supporting prevention strategies.

Authors:  Helen Lin; Jian-Ping Lu; Pierre Laflamme; Shengjun Qiao; Bobby Shayegan; Inna Bryskin; Lauren Monardo; Brian C Wilson; Gurmit Singh; Jehonathan H Pinthus
Journal:  Int J Oncol       Date:  2010-10       Impact factor: 5.650

5.  A new therapeutic approach to treat psoriasis by inhibition of fatty acid oxidation by Etomoxir.

Authors:  F Caspary; G Elliott; B T Navé; P Verzaal; M Rohrbach; P K Das; L Nagelkerken; J D Nieland
Journal:  Br J Dermatol       Date:  2005-11       Impact factor: 9.302

6.  Fatty acid oxidation contributes to IL-1β secretion in M2 macrophages and promotes macrophage-mediated tumor cell migration.

Authors:  Qi Zhang; Herui Wang; Chengyuan Mao; Mitchell Sun; Gifty Dominah; Liyuan Chen; Zhengping Zhuang
Journal:  Mol Immunol       Date:  2017-12-15       Impact factor: 4.407

7.  High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia.

Authors:  Jinlong Shi; Huaping Fu; Zhilong Jia; Kunlun He; Lin Fu; Weidong Wang
Journal:  EBioMedicine       Date:  2016-11-22       Impact factor: 8.143

8.  Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer.

Authors:  Roman Camarda; Alicia Y Zhou; Rebecca A Kohnz; Sanjeev Balakrishnan; Celine Mahieu; Brittany Anderton; Henok Eyob; Shingo Kajimura; Aaron Tward; Gregor Krings; Daniel K Nomura; Andrei Goga
Journal:  Nat Med       Date:  2016-03-07       Impact factor: 53.440

9.  Combination of Mitochondrial and Plasma Membrane Citrate Transporter Inhibitors Inhibits De Novo Lipogenesis Pathway and Triggers Apoptosis in Hepatocellular Carcinoma Cells.

Authors:  Wan-Angkan Poolsri; Phornpun Phokrai; Somrudee Suwankulanan; Narinthorn Phakdeeto; Pattamaphorn Phunsomboon; Dumrongsak Pekthong; Lysiane Richert; Sutatip Pongcharoen; Piyarat Srisawang
Journal:  Biomed Res Int       Date:  2018-01-09       Impact factor: 3.411

View more
  5 in total

1.  Synthesis and Preliminary Evaluation of an 18F-labeled Oleate Analog to Image Fatty Acid Beta-Oxidation in the Absence of Metabolic Defluorination.

Authors:  Yoshihiro Murakami; Yuji Fujita; Hiroshi Fushiki
Journal:  Mol Imaging Biol       Date:  2022-10-11       Impact factor: 3.484

Review 2.  The Role of Lipid Metabolism in Gastric Cancer.

Authors:  Meng-Ying Cui; Xing Yi; Dan-Xia Zhu; Jun Wu
Journal:  Front Oncol       Date:  2022-06-15       Impact factor: 5.738

3.  Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures.

Authors:  Shahid Aziz; Faisal Rasheed; Rabaab Zahra; Simone König
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 4.  Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis.

Authors:  Xiujing Yu; Shuyi Mi; Jun Ye; Guochun Lou
Journal:  J Cancer       Date:  2021-11-04       Impact factor: 4.207

5.  Effect of Expression of Nuclear-Encoded Cytochrome C Oxidase Subunit 4 Isoforms on Metabolic Profiles of Glioma Cells.

Authors:  Claudia R Oliva; Md Yousuf Ali; Susanne Flor; Corinne E Griguer
Journal:  Metabolites       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.